What This Means for Patients If you are waiting for retatrutide: it will not be available by prescription before late 2027 at the absolute earliest, and realistically Q1Q2 2028
More serious but less common risks include pancreatitis, gallbladder problems including gallstones, kidney issues including acute kidney failure in patients who experience severe vomiting or diarrhea, changes in vision, low blood sugar especially when combined with other diabetes medications, and increased heart rate
A good medication deserves a good framework
For diabetes patients specifically, TRANSCEND-T2D-1 suggests meaningfully better tolerability than the general obesity population worth factoring into expectation-setting
The best way to combat retatrutide fatigue is through careful meal planning, eating nutrient-rich foods and drinking enough water to stay energized
If youre considering GLP-1 therapy or injections, such as semaglutide or liraglutide, its natural to wonder: how long does GLP-1 actually stay in your system